Jacob Vogel
21 – 30 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
Biomarker-based staging of Alzheimer disease : rationale and clinical applications
- Contribution to journal › Scientific review
- 2023
-
Mark
Gray matter hypoperfusion is a late pathological event in the course of Alzheimer's disease
(2023) In Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 43(4). p.565-580
- Contribution to journal › Article
-
Mark
Connectome-based modelling of neurodegenerative diseases : towards precision medicine and mechanistic insight
- Contribution to journal › Scientific review
-
Mark
Novel data-driven subtypes and stages of brain atrophy in the ALS–FTD spectrum
- Contribution to journal › Article
-
Mark
The molecular genetic landscape of human brain size variation
- Contribution to journal › Article
-
Mark
Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA : Methodological limitations and convergent results
- Contribution to journal › Scientific review
-
Mark
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
- Contribution to journal › Article
-
Mark
Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies
- Contribution to journal › Article
- 2022
-
Mark
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
- Contribution to journal › Article
